Quick Answer
Scinai Immunotherapeutics Ltd. reported Net Income of $4.80 million for fiscal year 2024.
Scinai Immunotherapeutics Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | $4.80M | +173.8% |
| 2023 | -$6.50M | -12.1% |
| 2022 | -$5.80M | +29.4% |
| 2021 | -$8.21M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | -$3.52M | -42.0% | -42.0% |
| March 31, 2022 | -$2.48M | — | — |
- Scinai Immunotherapeutics Ltd. showed an increase of +173.8% in Net Income compared to the prior fiscal year.
- Over the 2021–2024 period, Scinai Immunotherapeutics Ltd.’s net income has grown by 158.4% (from -$8.21 million to $4.80 million).
- The most recent figure is from Scinai Immunotherapeutics Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: